NasdaqGS:OMCL - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,202	30	61	122	4
12/31/2025	1,144	19	35	111	8
12/31/2024	1,091	2	29	117	8
6/30/2024	1,080	-21	152	204	N/A
3/31/2024	1,103	-21	165	218	N/A
12/31/2023	1,147	-20	126	181	N/A
9/30/2023	1,186	-34	165	225	N/A
6/30/2023	1,235	-23	127	189	N/A
3/31/2023	1,268	-18	48	107	N/A
12/31/2022	1,296	6	17	78	N/A
9/30/2022	1,309	48	-5	55	N/A
6/30/2022	1,258	61	18	77	N/A
3/31/2022	1,199	72	98	158	N/A
12/31/2021	1,132	78	173	232	N/A
9/30/2021	1,070	80	195	249	N/A
6/30/2021	987	60	194	242	N/A
3/31/2021	914	35	164	218	N/A
12/31/2020	892	32	131	186	N/A
9/30/2020	891	38	86	144	N/A
6/30/2020	906	49	101	164	N/A
3/31/2020	924	69	85	144	N/A
12/31/2019	897	61	83	145	N/A
9/30/2019	860	54	98	158	N/A
6/30/2019	836	48	59	117	N/A
3/31/2019	807	38	55	112	N/A
12/31/2018	787	38	50	104	N/A
9/30/2018	772	54	8	61	N/A
6/30/2018	754	48	-19	27	N/A
3/31/2018	747	44	N/A	16	N/A
12/31/2017	713	31	N/A	25	N/A
9/30/2017	688	-1	N/A	45	N/A
6/30/2017	678	-6	N/A	72	N/A
3/31/2017	670	-9	N/A	56	N/A
12/31/2016	696	10	N/A	50	N/A
9/30/2016	651	8	N/A	54	N/A
6/30/2016	599	14	N/A	40	N/A
3/31/2016	539	24	N/A	44	N/A
12/31/2015	485	31	N/A	38	N/A
9/30/2015	476	32	N/A	37	N/A
6/30/2015	463	32	N/A	50	N/A
3/31/2015	455	31	N/A	75	N/A
12/31/2014	441	31	N/A	65	N/A
9/30/2014	425	28	N/A	49	N/A
6/30/2014	407	29	N/A	59	N/A
3/31/2014	395	27	N/A	52	N/A
12/31/2013	381	24	N/A	55	N/A
9/30/2013	365	23	N/A	53	N/A

アナリストによる今後の成長予測

収入対貯蓄率: OMCLは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.5% ) よりも高い成長率であると考えられます。

収益対市場: OMCL今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: OMCL今後 3 年以内に収益を上げることが予想されます。

収益対市場: OMCLの収益 ( 3.6% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: OMCLの収益 ( 3.6% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: OMCLの自己資本利益率は、3年後には低くなると予測されています ( 6.9 %)。

Omnicell 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Price target increased by 17% to US$38.29

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024

Consensus EPS estimates fall by 732%

Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year 2024

Omnicell, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Price target decreased by 28% to US$44.50

Recent updates

Omnicell, Inc. Announces Central Med Automation Service

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 17% to US$38.29

Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2024

Omnicell, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Now 20% undervalued

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Omnicell, Inc. Announces XT Amplify

Omnicell, Inc. to Report Q1, 2024 Results on May 02, 2024

Omnicell, Inc., Annual General Meeting, May 21, 2024

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

New minor risk - Shareholder dilution

High number of new directors

Omnicell, Inc. Announces Executive Changes

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell Is Building A Strong Moat

Consensus EPS estimates fall by 732%

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Omnicell, Inc. Reports Unaudited Impairment Changes Results for the Fourth Quarter Ended December 31, 2023

Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year 2024

Omnicell, Inc. to Report Q4, 2023 Results on Feb 08, 2024

Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Omnicell, Inc. Announces Board Changes

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Omnicell, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Price target decreased by 28% to US$44.50

Third quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 7.7% to US$64.14

Omnicell, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Omnicell, Inc. Announces Board Changes

Now 20% undervalued after recent price drop

Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

New minor risk - Shareholder dilution

Omnicell, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Omnicell, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Omnicell, Inc. Appoints Bobby Ghoshal to Board of Directors

Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

Founder recently bought US$295k worth of stock

A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Omnicell Announces Leadership and Organizational Changes

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Lead Independent Director exercised options and sold US$377k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Consensus EPS estimates fall by 19%

Omnicell, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Executive VP & Chief Commercial Officer notifies of intention to sell stock

Consensus forecasts updated

Consensus forecasts updated

Omnicell, Inc. to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022

Executive VP & Chief Commercial Officer notifies of intention to sell stock

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Price target decreased to US$84.44

Price target decreased to US$123